[HTML][HTML] EBCC-13 manifesto: balancing pros and cons for contralateral prophylactic mastectomy

MK Schmidt, JE Kelly, A Brédart, DA Cameron… - European Journal of …, 2023 - Elsevier
After a diagnosis of unilateral breast cancer, increasing numbers of patients are requesting
contralateral prophylactic mastectomy (CPM), the surgical removal of the healthy breast after …

Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice

L Lopez-Gonzalez, A Sanchez Cendra… - Medicina, 2024 - mdpi.com
Breast cancer is a prevalent malignancy in the present day, particularly affecting women as
one of the most common forms of cancer. A significant portion of patients initially present …

Chemoprevention and Lifestyle Modifications for Risk Reduction in Sporadic and Hereditary Breast Cancer

EDF Manna, D Serrano, G Aurilio, B Bonanni… - Healthcare, 2023 - mdpi.com
Female breast cancer is the most commonly diagnosed malignancy worldwide. Risk
assessment helps to identify women at increased risk of breast cancer and allows the …

[HTML][HTML] 2022 Association of Professors of Human and Medical Genetics (APHMG) consensus–based update of the core competencies for undergraduate medical …

LJ Massingham, S Nuñez, JA Bernstein, DP Gardner… - Genetics in …, 2022 - Elsevier
Purpose The field of genetics and genomics continues to expand at an unprecedented pace.
As scientific knowledge is translated to clinical practice, genomic information is routinely …

Implementation of BRCA mutations testing in formalin-fixed paraffin-embedded (FFPE) samples of different cancer types

G Zannini, G Facchini, M De Sio, F De Vita… - … -Research and Practice, 2023 - Elsevier
BRCA1 and BRCA2 are onco-suppressor genes involved in the DNA repair mechanism.
The presence of BRCA1/2 mutations confers a higher risk of developing several cancer …

Genetics, treatment, and new technologies of hormone receptor-positive breast cancer

W Sebastian, L Forchette, K Donoughe, Y Lun… - Cancers, 2023 - mdpi.com
Simple Summary In this review paper, we focused on the discussion of various important
aspects of hormone receptor (HR)-positive breast cancer, including HR structure and …

Factors influencing prophylactic surgical intervention in women with genetic predisposition for breast cancer

P Humar, Z Balogun, N Douglas… - Journal of Surgical …, 2024 - Wiley Online Library
Abstract Introduction In the United States, 5%–10% of breast cancer cases are due to
genetic predisposition. Among this population, prophylactic mastectomy is viable risk …

BRCA, infertility, and fertility preservation: a review for counseling

E Baltacı, F Kazancı, Fİ Şahin - Journal of Assisted Reproduction and …, 2023 - Springer
BRCA mutations as a triggering factor in breast cancer have been reported to result in
fertility problems and oocyte aging in young patients with cancer diagnosis. These patients …

A cost-effectiveness analysis of an integrated clinical-radiogenomic screening program for the identification of BRCA 1/2 carriers (e-PROBE study)

A Di Pilla, C Nero, ML Specchia, F Ciccarone… - Scientific Reports, 2024 - nature.com
Current approach to identify BRCA 1/2 carriers in the general population is ineffective as
most of the carriers remain undiagnosed. Radiomics is an emerging tool for large scale …

BRCA1/2 mutation carriers & risk reducing mastectomy: Who undergoes surgery and potential benefits

SM Record, SM Thomas, K Ntowe, A Chiba… - The American Journal of …, 2024 - Elsevier
Background Risk-reducing mastectomy (RRM) is the most effective breast cancer risk-
reduction strategy in BRCA1/2 mutation carriers. We examined factors associated with RRM …